3,4-Methylenedioxymethamphetamine (MDMA or 'Ecstasy') is a worldwide major drug of abuse known to elicit neurotoxic effects. The mechanisms underlying the neurotoxic effects of MDMA are not clear at present, but the metabolism of dopamine and 5-HT by monoamine oxidase (MAO), as well as the hepatic biotransformation of MDMA into pro-oxidant reactive metabolites is thought to contribute to its adverse effects.
Introduction
3,4-Methylenedioxymethamphetamine (MDMA or 'Ecstasy') is a strong psychoactive and mild hallucinogenic substance, which has become a major drug of abuse worldwide, over the last three decades (Hrometz et al., 2004; Capela et al., 2009) . MDMA consumption has received particular attention because several studies have documented its potential neurotoxicity (see Capela et al., 2009) . MDMA-mediated neurotoxicity in rats essentially affects 5-hydroxytryptaminergic neurons (O'Hearn et al., 1988; Bai et al., 2001) . On the other hand, high doses of MDMA administered to mice result in both dopaminergic and 5-hydroxytryptaminergic neurotoxicity (Stone et al., 1987; Cadet et al., 2001; Granado et al., 2008) . Several factors are thought to contribute to MDMAinduced neurotoxicity, namely hyperthermia, sustained receptor stimulation, inhibition of neurotransmitter synthesis, monoamine oxidase (MAO)-related metabolism of dopamine and 5-HT, dopamine oxidation and formation of neurotoxic metabolites of MDMA (Capela et al., 2009) . Oxidative stress is a common outcome of these factors and has an important role in the pathogenesis of MDMA, both in peripheral organs (Ninković et al., 2008; Carvalho et al., 2010; Shenouda et al., 2010) and in the CNS (Sanchez et al., 2003; Capela et al., 2007; Alves et al., 2009) . However, the relative contribution of each of these factors to the neurotoxicity of MDMA remains to be elucidated.
It is well known that MDMA induces an acute and rapid release of both 5-HT and dopamine from nerve endings, which may undergo oxidative deamination by MAO, leading to the formation of deleterious amounts of hydrogen peroxide (H 2O2) (Alves et al., 2007) . On the other hand, several studies failed to demonstrate 5-hydroxytryptaminergic neurotoxicity when MDMA or 3,4-methylenedioxyamphetamine (MDA) were injected directly into the brain, suggesting an important role for systemic metabolism in the neurotoxicity induced by these amphetamine derivatives (Bai et al., 1999; Esteban et al., 2001) . The hepatic metabolism of MDMA involves N-demethylation to MDA, which is also a well-known drug of abuse. MDMA and MDA are Odemethylenated to N-methyl-a-methyldopamine (N-Me-aMeDA) and a-methyldopamine (a-MeDA), respectively, both of which are catechols that can undergo oxidation to the corresponding o-quinones (Lim and Foltz, 1988; Pizarro et al., 2004) . In humans, N-Me-a-MeDA is the main plasma metabolite of MDMA, while a-MeDA is the main plasma metabolite in mice (de la Torre and Farré, 2004) . These o-quinones are highly redox active molecules that can undergo redox cycling, generating semiquinone radicals and leading to the formation of reactive oxygen species (ROS) and reactive nitrogen species (RNS) (Erives et al., 2008) . In addition, as the reactive o-quinone intermediates are electrophilic compounds, cellular damage can occur through alkylation of crucial cellular proteins and/or DNA (Capela et al., 2009) . In the presence of reduced glutathione (GSH), o-quinones may be conjugated to form a glutathionyl adduct (Hiramatsu et al., 1990) . This GSH conjugate remains redox active and is readily oxidized to the quinone-thioether, which can undergo further reaction with GSH and/or protein thiols (Miller et al., 1997) . The systemic formation of GSH conjugates of a-MeDA and N-Me-a-MeDA is followed by uptake and further metabolism in the brain, as GSH conjugates of N-Me-a-MeDA are present in the brain of rats given MDMA by s.c. injection (Jones et al., 2005; Erives et al., 2008) . Therefore, MDMA metabolites can be major effectors of MDMA neurotoxic effects, though the mechanisms behind their toxicity remain to be clarified.
The present study used mouse brain synaptosomes as an experimental model to further clarify the mechanisms of MDMA-induced neurotoxicity. Synaptosomes are a subcellular fraction, derived from neurons, prepared from brain tissue by homogenization and function as small anucleated cells that retain neuronal vesicles and enzymes. Usually, synaptosomes have one or more mitochondria and possess extremely active ion transport systems across their membranes (Nicholls, 1993; Whittaker, 1993) . Synaptosomes have been used successfully to study metabolic pathways, relationships between energy production and ion movements, neurotransmitter storage and synthesis, and mechanisms involved in neurotransmitters release, as well as oxidative damage to macromolecules and neuronal mitochondria (Nicholls, 1993; Erecinska et al., 1996) . Increased ROS formation in mouse brain synaptosomes proved to be a useful index of the neurotoxicity induced by MDMA (Chipana et al., 2006) . Also, several studies have been conducted in synaptosomes to assess the effects on neurotransmitter uptake induced by amphetamine derivatives (Kim et al., 2000; Pubill et al., 2005) .
In the present study, the pro-oxidant effects of MDMA and its metabolites a-MeDA, N-Me-a-MeDA and 5-(glutathion-S-yl)-a-methyldopamine
[5-(GSH)-a-MeDA], as well as those of 5-HT, dopamine, L-DOPA and 3,4-dihydroxyphenylacetic acid (DOPAC), were evaluated in mouse brain synaptosomes through the assessment of H2O2 production, oxidative stress biomarkers and formation of protein quinones. We also assessed the role of mitochondria and MAO metabolism in the neurotoxic process.
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Methods

Animals
All procedures were designed to minimize the number of animals used and their suffering, and were approved by the Portuguese Agency for Animal Welfare (general board of Veterinary Medicine in compliance with the Institutional Guidelines and the European Convention).
Adult male Swiss CD-1 mice (Charles River, Barcelona, Spain) weighting 30-40 g were used in all experiments. Animals were maintained under a 12 h light/dark cycle, in a temperature-and humidity-controlled room and given ad libitum access to food and water.
Preparation of mouse brain synaptosomes
Mouse brain synaptosomes were obtained as described elsewhere (Pubill et al., 2005; Chipana et al., 2006) with minor modifications. Briefly, on the morning of each assay, after weighing and anaesthetizing (sodium thiopental, 60 mg·kg -1 , i.p.) the animal, the brain was rapidly removed, weighed and placed in 20 volumes of cold homogenization buffer (5 mM Tris-HCl and 320 mM sucrose, pH 7.4). The mouse brain was homogenized using a borosilicate glass homogenizing tube fitted with a motor-driven Teflon pestle (10 strokes on ice). The homogenate was centrifuged at 1000¥ g, for 10 min, at 4°C. The supernatant was recovered, its volume was measured, and 1.6 M sucrose buffer (containing 5 mM Tris-HCl, pH 7.4) was added to a final sucrose concentration of 0.8 M. Samples were then centrifuged at 16 000¥ g, for 30 min, at 4°C, which gave a myelin-rich supernatant and a pellet (P2) consisting of mitochondria (brown-coloured) covered by a layer of synaptosomes (white). The supernatant was discarded, and the synaptosome layer was separated by carefully adding 1 mL of icecold 320 mM sucrose buffer (pH 7.4) and gently shaking the suspension. Finally, the synaptosome fraction was diluted in HBSS/glucose. All experiments were performed at a final protein concentration of 0.1 mg·mL -1 , except in assessment of mitochondrial damage, in which synaptosomes were used at a final protein concentration of 0.5 mg·mL -1
. Protein concentration was determined using the Bio-Rad DC protein assay kit, according to the manufacturer's specifications and using BSA solutions as standards.
Assessment of H 2 O 2 production
The formation of synaptosomal H2O2 was measured by fluorescence, using amplex red (25 mM) in the presence of 0.25 U·mL -1 horseradish peroxidase (HRP), as previously described (Tretter and Adam-Vizi, 2007) , with some adaptations. The method is based in the fact that H2O2 reacts with amplex red, a colourless and non-fluorescent compound, at a stoichiometry of 1:1, in a reaction catalysed by HRP to generate the highly fluorescent product resorufin. The fluorescence intensity is proportional to the H2O2 generation. Resorufin exhibits a maximum of fluorescence emission at a wavelength of 587 nm and maximum excitation at 563 nm. This is a very sensitive method for low concentrations of H2O2 (this procedure allows detection of 5 pmol H2O2 in a 96-well fluorescence assay microplate) (Zhou et al., 1997) . The synaptosomes were exposed to the drugs under study (6.25, 12.5, 25, 50, 100 and 200 mM) and fluorescence intensities of the reaction mixtures were measured at 37°C during 15 min, using a 96-well microplate in a fluorescence microplate reader (Synergy HT; Bio-Tek Instruments, VT) with a filter set for excitation and emission at 530 Ϯ 25 and 590 Ϯ 35 nm respectively. Each well contained 250 mL of synaptosomal suspension, 15 mL of HRP, 15 mL of amplex red and 10 mL of compound solution. The final volume in the well was fixed with HBSS/glucose to 300 mL. In the experiments conducted in the presence of MAO inhibitors (clorgyline 100 nM and deprenyl 10 nM), antioxidants (NAC 10 and 100 mM, ascorbic acid 10 and 100 mM and melatonin 0.5 and 1 mM) and FCCP (1 mM), synaptosomes were preincubated with these compounds in water bath, at 37°C, for 30 min. Based on the results obtained for H 2O2 production, the effects of antioxidants and FCCP were evaluated after incubation of synaptosomes with the drugs at a fixed concentration (50 mM). The MAO inhibitors' concentrations used in this study were selected from previous studies of MAO inhibition (Youdim et al., 2001; Aubin et al., 2004) . The FCCP concentration used here was selected from studies of maximal mitochondrial depolarization in neurons (Oliveira and Gonçalves, 2009 ) and synaptosomes (Tretter et al., 1998 
Assessment of lipid peroxidation
Lipid peroxidation was assessed by measuring malondialdehyde equivalents, using the thiobarbituric acid (TBA) assay (as TBA reactive substances -TBARS). After incubation of synaptosomes with different concentrations of compounds (6.25, 12.5, 25, 50 , 100 and 200 mM) in a water bath, at 37°C, samples of 150 mL were removed at selected time points (15, 30, 60, 120 and 180 min) and 300 mL of 10% trichloroacetic acid (TCA) (w/v) were added. The mixture was allowed to incubate on ice for 30 min before centrifugation at 16 000¥ g, for 10 min, at 4°C. After centrifugation, 250 mL of the supernatant was incubated with 250 mL of TBA reagent [1% TBA (w/v) in distilled water]. The mixture was heated at 95°C, for 10 min, and allowed to cool at room temperature. The malondialdehyde levels were estimated by spectrophotometric determination (PowerWaveX; Bio-Tek Instruments) at 535 nm. The effect promoted by 100 mM of NAC against lipid peroxidation was evaluated after incubating synaptosomes with the MDMA metabolite 5-(GSH)-a-MeDA, at the concentration of 200 mM. The amount of malondialdehyde equivalents was calculated using a molar extinction coefficient of 1.56 ¥ 10 5 mol·cm -1 , and the final result was expressed as nmol malondialdehyde Eq·mg -1 protein.
Assessment of protein-bound quinones (quinoproteins)
Protein-bound quinones were assessed by the NBT/glycinate colorimetric assay, as previously described , with a few adaptations. 
Assessment of protein carbonylation
Protein carbonyls, an index of protein oxidation, were determined as previously described (Magalhães et al., 2007) , with adaptations. After incubation of synaptosomes with 200 mM of the different compounds in a water bath at 37°C, for 2 h, 2 mL sample aliquots were removed and centrifuged at 16 000¥ g, for 15 min, at 4°C. The supernatant was discarded, and the pellet was dispersed in 300 mL of phosphate buffer (50 mM KH2PO4 and 1 mM EDTA, pH 6.7), sonicated and again centrifuged at 10 000¥ g, for 15 min, at 4°C. Protein concentrations of all samples were determined using the BioRad DC protein assay kit, and all samples were diluted down to a final protein concentration of 0.1 mg·mL . Derivatized proteins (0.2 mg) were loaded into nitrocellulose membrane under vacuum using a slot blot apparatus. Then, after washing in Tris-buffered saline solution (TBS:10 mM Tris-HCl, 150 mM NaCl, pH 8.0), the membrane was blocked in blocking buffer [5% non-fat powdered skim milk (w/v) in TBS with 0.05% Tween 20 (v/v) (TBS-T)] overnight, at 4°C. The membrane was then incubated with primary antibody (rabbit polyclonal anti-DNP, 1:1000) for 1.5 h. After incubation with the primary antibody, membranes were rinsed two times with TBS-T and added with the secondary antibody (anti-rabbit IgG-peroxidase, 1:2000) for 1 h. Antibodies were diluted in blocking buffer. Following two washes in TBS-T, bands were visualized by treating the immunoblots with ECL Plus chemiluminescence reagents (Amersham Pharmacia Biotech), according to the supplier's instructions, and developed on high performance chemiluminescence films (Amersham Pharmacia Biotech) with Kodak Film Developer and Kodak Fixer (Sigma-Aldrich). Bands in the films were quantified using the Image J software (National Institutes of Health). Optical density results were expressed as % of control values.
Assessment of glutathione levels
The GSH and GSSG levels of the synaptosomes were determined by the DTNB-GSH reductase recycling assay as previously described (Carvalho et al., 2004a) , with adaptations. After exposure of the synaptosomes to the tested compounds at the concentrations of 50 and 200 mM in water bath, at 37°C, 2 mL sample aliquots were collected at selected time points (1 and 2 h) and centrifuged at 16 000¥ g, for 15 min, at 4°C. The supernatant (600 mL) was collected, and 200 mL HClO4 20% (w/v) was added. The pellet was dispersed in 250 mL of HClO4 5% (w/v) and again centrifuged at 16 000¥ g, for 5 min, at 4°C. In sample aliquots, the perchloric acid pellet was dissolved in 250 mL of NaOH 0.3 M, and the protein content was assayed by the Lowry method (Lowry et al., 1951) , using BSA solutions as standards. The supernatants (200 mL) were neutralized with an equimolar solution of KHCO3 (0.76 M) and centrifuged at 16 000¥ g, for 5 min, at 4°C. For GSSG quantification, aliquots (200 mL) of acidic supernatant were added of 10 mL 2-vinylpyridine and shaked continuously during 1 h to block free SH groups. In 96-well plates, 100 mL of sample, standard or blank were added in triplicate and mixed with 65 mL of fresh reagent solution containing 1.3 mM 5,5-dithio-bis(2-nitrobenzoic acid) (DTNB) and 0.24 mM b-NADPH dissolved in phosphate buffer (71.5 mM Na2HPO4, 71.5 mM NaH2PO4 and 0.63 mM EDTA, pH 7.5). Plates were then incubated in a plate reader (PowerWaveX; Bio-Tek Instruments) at 30°C during 15 min prior to the addition of 40 mL of fresh GR solution per well (10 U·mL -1 in phosphate buffer). The stoichiometric formation of 5-thio-2-nitrobenzoic acid (TNB) was followed for 3 min at 415 nm and compared with a standard curve. GSH and GSSG standard solutions were prepared in HClO4 5% (w/v). The effect of buthionine sulphoximine (BSO) on GSH levels was evaluated after incubating synaptosomes with the drugs, at the concentration of 200 mM, for 1 h. GSH and GSSG contents were normalized to the total protein content, and the final result was expressed as nmol GSH or GSSG·mg -1 protein or mM GSH in the supernatant.
Assessment of mitochondrial integrity
To assess mitochondrial integrity, synaptosomes exposed to drugs, at the concentration of 200 mM, for 1 h, were subsequently incubated with 50 nM tetramethylrhodamine methyl ester (TMRM) and imaged by fluorescence microscopy as previously described (Oliveira and Gonçalves, 2009) , during 2 h. The imaging system consisted of an inverted epifluorescence microscope (Eclipse TE300; Nikon, Tokyo, Japan) equipped with a 60¥ air objective, a monochromator (Polychrome II; TILL Photonics, Martinsried, Germany) and a CCD camera (C6790; Hamamatsu Photonics, Hamamatsu, Japan). In each experiment, synaptosomal preparations were sampled in triplicate, by placing 20 mL of the synaptosomal suspension between glass slide and coverslip and processed with the automated acquisition of 20 random fields. The number of mitochondria (TMRM-labelled puncta, as confirmed by FCCP-induced fluorescence decay) was quantified by particle analysis using custom built macros in Image J (National Institutes of Health). Results (average number of polarized mitochondria per field) are presented as % of control.
Statistical analysis
Results are presented as mean Ϯ SD from four to six independent experiments, with synaptosomes derived from the same number of different animals. All data were analysed using parametric tests. Statistical comparisons between groups were performed with one-way ANOVA followed by the Newman-Keuls multiple comparison post hoc test, for experiments with one variable. Two-way ANOVA followed by the Bonferroni's multiple comparison post hoc test, was used in experiments with two variables. Details of the statistical analysis are described in each figure legend. Differences were considered to be statistically significant at P-values lower than 0.05. All analyses were performed using GraphPad Prism 5.0 for Windows (GraphPad Software, San Diego, CA).
Materials
All reagents used in this study were of analytical grade or of the highest grade available. The following reagents were obtained from Sigma-Aldrich (St. Louis, MO):
acid, melatonin, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP), thiobarbituric acid (TBA), PMSF, nitro blue tetrazolium (NBT), sodium glycinate, GSH, oxidized glutathione (GSSG), b-NADPH, 5,5-dithio-bis(2-nitrobenzoic acid) (DTNB), glutathione reductase (GR), buthionine sulphoximine (BSO) and bovine serum albumin (BSA). Rabbit polyclonal anti-DNP antibody and tetramethylrhodamine methyl ester (TMRM) were obtained from Invitrogen (Carlsbad, CA). Anti-rabbit IgG-peroxidase antibody was purchased from Amersham Pharmacia Biotech (Buckinghamshine, United Kingdom). Bio-Rad DC protein assay kit was purchased from Bio-Rad Laboratories (Hercules, CA). HClO4, NaOH, absolute ethanol, dimethylsulphoxide (DMSO) and Folin reagent were obtained from Merck (Darmstadt, Germany). Sodium thiopental was obtained from B. Braun (Lisbon, Portugal). MDMA (hydrochloride salt) was extracted and purified from high-purity MDMA tablets that were kindly provided by the Portuguese Criminal Police Department. The obtained salt was pure and fully characterized by NMR and mass spectrometry methodologies. The MDMA metabolites a-MeDA, N-Me-a-MeDA and 5-(GSH)-a-MeDA were synthesized and fully characterized by NMR and mass spectrometry methodologies by REQUIMTE/ CQFB (Centro de Química Fina e Biotecnologia), Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, according to methods previously published by our group (Capela et al., 2006; Macedo et al., 2007) . All other chemicals were purchased from Sigma-Aldrich. 5-HT, dopamine, DOPAC, MAO inhibitors clorgyline and deprenyl, NAC and ascorbic acid were dissolved in HEPES-buffered salt solution with glucose (HBSS/glucose: 140 mM NaCl, 5.37 mM KCl, 1.26 mM CaCl2, 0.44 mM KH2PO4, 0.49 mM MgCl2·6H2O, 0.41 mM MgSO4(7H2O, 4.17 mM NaHCO3, 0.34 mM Na2HPO4·7H2O, 20 mM HEPES-Na and 5.5 mM glucose, pH 7.4). HRP, BSO, MDMA and MDMA metabolites were dissolved in distilled water. L-DOPA was solubilized in 10 mM HCl. Amplex red and TMRM were dissolved in DMSO. PMSF and melatonin were solubilized in absolute ethanol. FCCP was dissolved in 95% of ethanol. Controls received an equivalent amount of vehicle.
Results
MDMA metabolites, monoamine neurotransmitters, L-DOPA and DOPAC induced H 2 O 2 generation in a concentrationand time-dependent manner
Mouse brain synaptosomes were exposed to growing concentrations of the different compounds (6.25-200 mM) and assayed for H2O2 generation, using an amplex red method. Incubation of synaptosomes with MDMA metabolites a-MeDA, N-Me-a-MeDA and 5-(GSH)-a-MeDA, as well as 5-HT, dopamine, L-DOPA and DOPAC significantly increased H2O2 production (Figure 1 ) in a concentration-and timedependent manner. On the other hand, MDMA did not significantly increase the H2O2 formation at any of the evaluated concentrations during the time course of the experiment ( Figure 1A ). For N-Me-a-MeDA, 5-HT, L-DOPA and DOPAC, there was a statistically significant amount of H2O2 at the lowest concentration studied (6.25 mM) (Figure 1C,E,G,H) . The other compounds generated a significant amount of H2O2 only at 12.5 mM or above ( Figure 1B,D,F) . The MDMA metabolite 5-(GSH)-a-MeDA was the most effective generator of H2O2, under our conditions. In experiments conducted in the absence of amplex red, no auto-fluorescence was observed for all studied compounds (data not shown). , from 10 to 15 min], when synaptosomes were pre-incubated with MAO-A and/or MAO-B selective inhibitors clorgyline (100 nM) and deprenyl (10 nM), respectively. There were no significant differences in basal H2O2 production between synaptosomes pre-incubated with MAO inhibitor(s) and non pre-incubated synaptosomes. Pre-incubation of synaptosomes with clorgyline blocked H2O2 production for all concentrations of 5-HT tested (Figure 2A ). However, for dopamine ( Figure 2B ), clorgyline decreased H2O2 generation only at the highest dopamine concentration tested (200 mM) (P < 0.001), with similar effects for deprenyl (P < 0.05) ( Figure 2B ). On the other hand, MAO-B inhibition with deprenyl did not affect H2O2 generation by 5-HT (Figure 2A) . In another set of experiments, the results of preincubation with clorgyline and deprenyl were similar to those obtained with clorgyline alone (Figure 2C-D) . For the other compounds, pretreatment of synaptosomes with MAO inhibitors had no effect on H2O2 production (data not shown).
DA-and 5-HT-induced H 2 O 2 production was dependent on MAO-related metabolism
Figure 1
H2O2 generation induced by MDMA (A), its metabolites a-MeDA (B), N-Me-a-MeDA (C) and 5-(GSH)-a-MeDA (D), monoamine neurotransmitters 5-HT (E) and dopamine (F), as well as the dopamine precursor L-DOPA (G) and dopamine metabolite DOPAC (H), in mouse brain synaptosomes, evaluated by the amplex red method. Synaptosomes were exposed, for 15 min, to increasing concentrations (6.25, 12.5, 25, 50, 100 and 200 mM) of the compounds, and measurements were made at six different time points. Results are presented as mean Ϯ SD from 5 independent experiments for panel A and 6 independent experiments for panels B-H, expressed in mFU (arbitrary units). Statistical comparisons were made using two-way ANOVA with repeated measures followed by the Bonferroni's multiple comparison post hoc test [*P < 0.05, **P < 0.01, ***P < 0.001 concentration vs. control (0 mM); Figure 3 shows the antioxidant effects of 10 mM NAC, 10 mM ascorbic acid and 0.5 mM melatonin, on H2O2 production. Ascorbic acid, by itself, increased H2O2 generation. For the MDMA metabolite a-MeDA, (Figure 3A ), NAC (P < 0.05), ascorbic acid (P < 0.001) and melatonin (P < 0.001) decreased H2O2 production. Ascorbic acid decreased H2O2 production by N-Me-a-MeDA ( Figure 3B ) more effectively. On the other hand, for the MDMA metabolite 5-(GSH)-a-MeDA ( Figure 3C ) and 5-HT ( Figure 3D ), only melatonin decreased H2O2 levels (P < 0.001). Both ascorbic acid and melatonin decreased (P < 0.001) H2O2 levels generated by dopamine ( Figure 3E ). All three antioxidants decreased H2O2 levels resulting from incubation with L-DOPA (P < 0.001 for all antioxidants) ( Figure 3F ). In contrast with all other studied compounds, for DOPAC ( Figure 3G ), only ascorbic acid was able to decrease H2O2 levels (P < 0.001) but with NAC, there was actually an abrupt increase. When higher concentrations (100 mM) of the antioxidants were tested, only NAC and ascorbic acid inhibited H2O2 production induced by N-Me-a-MeDA (P < 0.001), while in the case of L-DOPA, only 100 mM of NAC significantly decreased H2O2 levels (P < 0.001) (data not shown).
Also, the effects elicited by a higher concentration of melatonin (1 mM) were not significantly different from 0.5 mM for all compounds tested (data not shown). Thus, among the antioxidants studied, melatonin showed the highest antioxidant effects against H2O2 production induced by the different compounds.
H 2 O 2 production induced by the tested compounds was unaffected by prior mitochondrial depolarization
To investigate if H2O2 production induced by the different compounds had a mitochondrial source, we used the protonophore FCCP that depolarizes mitochondria by collapsing the proton gradient across the mitochondrial inner membrane and dissipating mitochondrial membrane potential. Table 1 shows that FCCP (1 mM) did not affect either the basal H2O2 production or that induced by any of the evaluated compounds. In experiments conducted by realtime fluorescence videomicroscopy, we confirmed that the FCCP concentration used in this study was able to completely collapse the mitochondrial membrane potential (data not shown). Thus, in our experimental conditions, the H2O2 production induced by all tested compounds was independent of the mitochondrial polarization status,
Figure 2
Effect of clorgyline (MAO-A inhibitor) or deprenyl (MAO-B inhibitor) on H2O2 generation induced by 5-HT and dopamine, in mouse brain synaptosomes, evaluated by the amplex red method. Synaptosomes were exposed, for 15 min, to increasing concentrations (6.25, 12.5, 25, 50, 100 and 200 mM) of 5-HT (A) or dopamine (B) either with or without clorgyline (100 nM) or deprenyl (10 nM) pre-incubation. On another set of experiments, synaptosomes were pre-incubated with clorgyline (100 nM) plus deprenyl (10 nM) before exposure to 5-HT (C) and dopamine (D). Results are presented as mean Ϯ SD from 6 independent experiments, expressed by the slope of the reading [mFU (arbitrary units)·min -1 , from 10 to 15 min]. Statistical comparisons were made using two-way ANOVA followed by the Bonferroni's multiple comparison post hoc test [*P < 0.05, **P < 0.01, ***P < 0.001 monoamine plus MAO inhibitor(s) vs. monoamine].
Figure 3
Protective effect of NAC, ascorbic acid and melatonin against H2O2 generation induced by the MDMA metabolites a-MeDA (A), N-Me-a-MeDA (B) and 5-(GSH)-a-MeDA (C), 5-HT (D), dopamine (E), L-DOPA (F) and DOPAC (G) in mouse brain synaptosomes, evaluated by the amplex red method. Synaptosomes, with or without antioxidant pre-incubation (10 mM of NAC and ascorbic acid or 0.5 mM of melatonin), were exposed for 15 min to the compounds, at the concentration of 50 mM. Results are presented as mean Ϯ SD from 6 independent experiments, expressed by the slope of the reading [mFU (arbitrary units)·min -1 , from 10 to 15 min]. Statistical comparisons were made using one-way ANOVA followed by the Newman-Keuls multiple comparison post hoc test (***P < 0.001 compound vs. control; ++ P < 0.01, +++ P < 0.001 antioxidant vs. control; # P < 0.05, ### P < 0.001 compound plus antioxidant vs. compound).
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excluding a significant role of the organelle's respiratory chain in the H2O2-generating mechanism.
MDMA metabolite 5-(GSH)-a-MeDA concentration-and time-dependently induced lipid peroxidation, an effect prevented by NAC
Lipid peroxidation induced by the compounds in mouse brain synaptosomes was evaluated by the TBA assay. As shown in Figure 4 , the MDMA metabolite 5-(GSH)-aMeDA induced lipid peroxidation in a concentration-and time-dependent manner, reaching significance at 120 min ( Figure 4A ). For the remaining compounds, we did not observe significant differences from control at any of concentrations and incubation times studied (data not shown). Experiments were conducted to verify the ability of this metabolite to react directly with the TBA. After exposure of the MDMA metabolite directly with TBA in HBSS/glucose, we verified the absence of any reaction, excluding also the possibility of reaction with the final products of the lipid peroxidation (data not shown).
Pre-incubation of synaptosomes with NAC (100 mM), inhibited lipid peroxidation mediated by 5-(GSH)-a-MeDA (200 mM) ( Figure 4B ). Other antioxidant treatments (NAC 10 mM, ascorbic acid 10 and 100 mM, or melatonin 0.5 and 1 mM) did not change lipid peroxidation induced by 5-(GSH)-a-MeDA (data not shown).
MDMA metabolites a-MeDA, N-Me-a-MeDA and 5-(GSH)-a-MeDA, as well as dopamine, L-DOPA and DOPAC increased the formation of protein-bound quinones, in a concentration-dependent manner
To assess the role of quinones in the deleterious potential of the different studied compounds, we evaluated the levels of protein-bound quinones (quinoproteins). Although different incubation times were tested (20, 30 and 60 min), formation of protein-bound quinones was not time-dependent, and, thus, only the results obtained at 30 min time point are presented ( Figure 5 ). MDMA and 5-HT did not generate quinoproteins, at any of the concentrations studied (data not shown). The other compounds increased quinoprotein levels, in a concentration-dependent manner (Figure 5 ), and the most effective was the MDMA metabolite N-Me-a-MeDA, with a significant formation of quinoproteins at the lowest concentration studied (6.25 mM) (P < 0.05) ( Figure 5B ). The antioxidants NAC (10 and 100 mM), ascorbic acid (10 and 100 mM) and melatonin (0.5 and 1 mM) did not prevent the formation of quinoproteins (data not shown).
The MDMA metabolite 5-(GSH)-a-MeDA and DOPAC induced a significant carbonylation of synaptosomal proteins
To evaluate possible oxidative effects to synaptosomal proteins, we also studied the protein carbonylation by an immunoblotting method. As presented in Figure 6 , the levels of protein carbonyls in the synaptosomes were raised by incubation with the MDMA metabolite 5-(GSH)-a-MeDA or DOPAC (200 mM), for 2 h (P < 0.05) but not by the other compounds (data not shown). Figure 7 shows the glutathione status in synaptosomes after incubation with 50 and 200 mM of the tested compounds for 1 and 2 h. Incubation of synaptosomes, for 1 h, with 50 mM of MDMA metabolites a-MeDA, N-Me-a-MeDA and 5-(GSH)-a-MeDA and dopamine increased total GSH levels (P < 0.001, P < 0.01, P < 0.01 and P < 0.01 respectively) ( Figure 7A ), without affecting GSSG levels ( Figure 7E) . After 2 h, there was also a significant increase in total GSH levels, only for the MDMA metabolite a-MeDA and dopamine (P < 0.01) ( Figure 7B ), without changing GSSG levels ( Figure 7F ). , from 10 to 15 min]. Statistical comparisons were made using one-way ANOVA followed by the Newman-Keuls multiple comparison post hoc test.
Incubation of synaptosomes with MDMA metabolites a-MeDA, N-Me-a-MeDA and 5-(GSH)-a-MeDA, as well as 5-HT, dopamine, L-DOPA and DOPAC altered the intra-synaptosomal glutathione status
However, for the MDMA metabolite 5-(GSH)-a-MeDA, GSSG levels were significantly increased at this time point (P < 0.05) ( Figure 7F ). When synaptosomes were incubated with 200 mM of the different compounds, for 1 h, it was observed a significant increase in total GSH levels for all compounds, except for MDMA and DOPAC (P < 0.05 for a-MeDA, N-Mea-MeDA, 5-(GSH)-a-MeDA, 5-HT and dopamine, and P < 0.01 for L-DOPA) ( Figure 7C ). For N-Me-a-MeDA, 5-(GSH)-a-MeDA and dopamine, the increase in total GSH levels were accompanied by significant elevations of GSSG levels (P < 0.01, P < 0.001 and P < 0.001, respectively) ( Figure 7G ). Incubation of synaptosomes with the different compounds at a concentration of 200 mM, for 2 h, resulted in significant increases in total GSH levels only after exposure to 5-HT (P < 0.05) and L-DOPA (P < 0.001) ( Figure 7D ), which were accompanied by increased GSSG levels (P < 0.001 and P < 0.01 respectively) ( Figure 7H ). At the same time point, 200 mM N-Me-a-MeDA, 5-(GSH)-a-MeDA, dopamine and DOPAC also promoted a significant increase in GSSG levels (P < 0.01, P < 0.001, P < 0.001 and P < 0.01, respectively) ( Figure 7H) .
In order to explain the increase of total GSH levels without concomitant elevations in the GSSG levels, we used BSO, a selective and potent inhibitor of g-glutamylcysteine ligase (the enzyme catalysing the rate limiting step in GSH biosynthesis), and measured total GSH levels in the incubation medium after incubation with the different compounds (200 mM; 1 h). Preincubation of synaptosomes with BSO ( Figure 8A ) did not modify the basal GSH content of synaptosomes or that after incubation with the compounds. However, in the supernatant, total GSH levels decreased (P < 0.05 for N-Me-a-MeDA, P < 0.01 for 5-HT and L-DOPA and P < 0.001 for a-MeDA, 5-(GSH)-a-MeDA, dopamine and DOPAC) ( Figure 8B ), but GSSG levels remained below the detection limit of the method. Thus, the increase in total GSH levels observed did not result from an increase in its synthesis, as ascertained by the use of BSO, but rather to the uptake from the incubation medium.
Figure 4
(A) Lipid peroxidation induced by the MDMA metabolite 5-(GSH)-a-MeDA in mouse brain synaptosomes, evaluated by the TBA assay (TBARS). Synaptosomes were exposed, for 3 h, to increasing concentrations (6.25, 12.5, 25, 50, 100 and 200 mM) of MDMA metabolite 5-(GSH)-a-MeDA, and measurements were made at 5 different time-points (15, 30, 60, 120 and 180 min). (B) Protective effect of NAC against lipid peroxidation induced by the MDMA metabolite 5-(GSH)-a-MeDA, in mouse brain synaptosomes, evaluated by the TBA assay (TBARS). Synaptosomes were exposed for 3 h to MDMA metabolite 5-(GSH)-a-MeDA, at the concentration of 200 mM, in the presence or absence of NAC (100 mM). Results are presented as mean Ϯ SD from n = 6 independent experiments, expressed in nmol malondialdehyde Eq·mg -1 protein. Statistical comparisons were made using two-way ANOVA followed by the Bonferroni's multiple comparison post hoc test [**P < 0.01, ***P < 0.001 concentration vs. control (0 mM); +++ P < 0.001 5-(GSH)-a-MeDA plus NAC vs. 5-(GSH)-a-MeDA].
Oxidative stress induced by MDMA metabolites N-Me-a-MeDA and 5-(GSH)-a-MeDA and 5-HT did not alter the number of polarized mitochondria
To evaluate possible effects of 5-HT, N-Me-a-MeDA and 5-(GSH)-a-MeDA on mitochondrial integrity, we quantified the number of polarized mitochondria labelled with TMRM (50 nM). Representative images of the synaptosomes and their mitochondria are depicted in Figure 9A (bright field) and Figure 9B (TMRM fluorescence). As shown in Figure 9C , the number of polarized mitochondria after incubation of the synaptosomes, for 1 h, with 200 mM of 5-HT, N-Me-a-MeDA or 5-(GSH)-a-MeDA, was not different from the controls.
Discussion
Key findings of our study in synaptosomes were as follows: (i) MDMA metabolites a-MeDA, N-Me-a-MeDA and 5-(GSH)-aMeDA, as well as 5-HT, dopamine, L-DOPA and DOPAC induced extensive H2O2 generation, in a concentration-and time-dependent manner; (ii) H2O2 production induced by 5-HT was fully dependent on MAO-A metabolism, while for dopamine, it was partly dependent on both MAO-A and MAO-B; (iii) NAC, ascorbic acid and melatonin decreased H2O2 levels in synaptosomes exposed to MDMA metabolites, as well as 5-HT, dopamine, L-DOPA and DOPAC; (iv) H2O2 production promoted by the tested compounds was independent of mitochondrial polarization status; (v) the MDMA metabolite 5-(GSH)-a-MeDA induced lipid peroxidation in a concentration-and time-dependent manner, an effect prevented by NAC; (vi) formation of protein-bound quinones (quinoproteins) induced by the studied compounds, except MDMA and 5-HT, was concentration-dependent but timeindependent; (vii) MDMA metabolite 5-(GSH)-a-MeDA and DOPAC induced protein carbonylation; (viii) all studied compounds, except MDMA, altered the synaptosomal glutathione status; and (ix) MDMA metabolites presented a higher toxic potential than the parent compound MDMA, with 5-(GSH)-a-MeDA promoting higher oxidative stress. Although MDMA is known to promote brain oxidative stress in laboratory animals (Alves et al., 2007; Granado et al., 2008) , the underlying mechanisms remain largely unknown. MDMA metabolites can be major contributors (Capela et al., 2006; , and there is a role for dopamine
Figure 5
Protein-bound quinones (quinoproteins) induced by the MDMA metabolites a-MeDA (A), N-Me-a-MeDA (B) and 5-(GSH)-a-MeDA (C), as well as by dopamine (D), L-DOPA (E) and DOPAC (F), in mouse brain synaptosomes, evaluated by the NBT/glycinate colorimetric assay. Synaptosomes were exposed to increasing concentrations of the compounds (6.25, 12.5, 25, 50, 100 and 200 mM) , and measurements were made after 30 min. Results are presented as mean Ϯ SD from 6 independent experiments, expressed as OD 530 nm·mg -1 protein. Statistical comparisons were made using one-way ANOVA followed by the Newman-Keuls multiple comparison post hoc test [*P < 0.05, **P < 0.01, ***P < 0.001 concentration vs. control (0 mM)].
and 5-HT in MDMA-induced neurotoxicity (Hrometz et al., 2004) . We found that the monoamine neurotransmitters 5-HT and dopamine, as well as the dopamine precursor (L-DOPA) and its metabolite (DOPAC), increased H2O2 production ( Figure 1E-H) .
After MDMA administration to experimental animals, there is an abrupt increase in the extravesicular levels of monoamine neurotransmitters inside nerve endings, which are metabolized by MAO (Alves et al., 2007) and a byproduct of MAO action is H2O2, which subsequently may be converted into the hydroxyl radical, a highly cytotoxic ROS (Nagatsu, 2004) . In mouse brain synaptosomes, H2O2 generation induced by dopamine and 5-HT was MAO-dependent, MAO-A being the only source of H2O2 for 5-HT (Figure 2 ). Previous studies from our group established that MAOdependent metabolism contributed to MDMA-induced mitochondrial neurotoxicity (Alves et al., 2007; . Although 5-HT has been shown to be metabolized in vitro both by MAO-A (Km = 178 Ϯ 2 mM) and MAO-B (Km = 1170 Ϯ 432 mM), metabolism by MAO-B is minimal in the presence of MAO-A (Shih et al., 1999) . However, MAO-B is fully effective in the absence of MAO-A, as when metabolism occurs inside 5-hydroxytryptaminergic nerves (Alves et al., 2009) . Thus, our results agree with previously published studies in which 5-HT metabolism is associated with MAO-A, while dopamine metabolism is both MAO-A-and MAO-B-dependent (Nagatsu, 2004) .
MAO-catalysed dopamine metabolism has DOPAC as a final product. Here, DOPAC induced extensive H 2O2 formation that may be involved in dopamine-associated MDMA neurotoxicity. Accordingly, DOPAC and its aldehyde precursor 3,4-dihydroxyphenylacetaldehyde were described as possible neurotoxic agents in MAO-associated oxidative damage (Burke et al., 2003) .
5-HT is readily oxidized and, simultaneously, acts as a ROS scavenger (Uemura et al., 1980) . The dimer 5,5′-dihydroxy-4,4′-bitryptamine is the major product of 5-HT auto-oxidation at physiological pH and temperature, being formed in the presence of H2O2 and peroxidase (Wrona and Dryhurst, 1988) . In the presence of MAO-A inhibitor clorgyline, we observed lower H2O2 levels after exposure of synaptosomes to 5-HT, relative to that of control values, which can be explained by H2O2 consumption during the formation of 5-HT dimers in control conditions, as previously observed in cultured rat microglia (Huether et al., 1997) .
As demonstrated by several studies (Gollamudi et al., 1989; Bai et al., 1999; Esteban et al., 2001) , metabolism is required for MDMA neurotoxicity. Our results showed that MDMA metabolites, in mouse brain synaptosomes, induce a significant production of H2O2 in a concentration-and timedependent manner, an effect that was not observed for the parent compound MDMA (Figure 1A-D) . According to these results, MDMA metabolites exhibit higher neurotoxic potential than MDMA, as previously observed in rat cortical neurons (Capela et al., 2006; . Also, in other cell types, like rat cardiomyocytes (Carvalho et al., 2004c) , rat hepatocytes (Carvalho et al., 2004b) and rat and human renal proximal tubular cells (Carvalho et al., 2002) , MDMA metabolites presented a higher toxic potential than the parent compound MDMA. Other reports indicate that peripheral metabolism of N-Me-a-MeDA and a-MeDA is required for neurotoxic events (Miller et al., 1996) . In fact, the conjugate 5-(GSH)-a-MeDA, which can be transported into the brain (Miller et al., 1996) , was the most potent H2O2 generator. Thus, our findings are consistent with previous studies, in which we demonstrated that conjugated metabolites of the catechols exhibited a higher neurotoxic potential in rat cortical neurons (Capela et al., 2006; .
The mechanism underling the toxicity of MDMA metabolites is thought to involve the inherent reactivity of their catechol moiety (Carvalho et al., 2004b) . MDMA metabolites a-MeDA, N-Me-a-MeDA and 5-(GSH)-a-MeDA, as well as dopamine, L-DOPA and DOPAC are prone to the oxidation to the corresponding o-quinones (Spencer et al., 1998; Macedo et al., 2007) , which may further undergo redox cycling and generate the extensive H2O2 production observed in our studies. Therefore, antioxidants are expected to reduce not only o-quinones-related injury, but also the deleterious effects mediated by ROS and RNS. Accordingly, we observed that the antioxidants NAC, ascorbic acid and melatonin partially prevented the increase of H2O2 levels induced by MDMA metabolites a-MeDA, N-Mea-MeDA and 5-(GSH)-a-MeDA, as well as by 5-HT, dopamine, L-DOPA and DOPAC (Figure 3) . ROS, being normal products of mitochondrial respiration (Adam-Vizi, 2005) , are assumed to play a key role in the MDMA-related neurotoxicity (Cadet et al., 1995;  
Figure 6
Protein carbonylation induced by 200 mM of the MDMA metabolite 5-(GSH)-a-MeDA and DOPAC, after exposure of synaptosomes for 2 h, evaluated by an immunoblotting method. Results are presented as mean Ϯ SD from 4 independent experiments, expressed in percentage of control, which values were set to 100%. Statistical comparisons were made using one-way ANOVA followed by the Newman-Keuls multiple comparison post hoc test (*P < 0.05 compound vs. control).
Figure 7
Effects of MDMA, its metabolites a-MeDA, N-Me-a-MeDA and 5-(GSH)-a-MeDA, as well as 5-HT, dopamine, L-DOPA and DOPAC, on total GSH and GSSG levels, in mouse brain synaptosomes, evaluated by the DTNB/GSH reductase recycling assay. Intra-synaptosomal total GSH (A, B, C and D) and GSSG levels (E, F, G and H) are presented. Synaptosomes were exposed to MDMA, its metabolites a-MeDA, N-Me-a-MeDA and 5-(GSH)-a-MeDA, as well as 5-HT, dopamine, L-DOPA and DOPAC, for 1 h (A, C, E and G) and 2 h (B, D, F and H), at the concentrations of 50 (A, B, E and F) and 200 mM (C, D, G and H). Results are presented as mean Ϯ SD from 6 independent experiments, expressed in nmol GSH or GSSG·mg -1 protein. Statistical comparisons were made using one-way ANOVA followed by the Newman-Keuls multiple comparison post hoc test (*P < 0.05, **P < 0.01, ***P < 0.001 compound vs. control). Sanchez et al., 2003) . Although studies on isolated mitochondria have identified complex I and complex III as possible sites of ROS generation in the respiratory chain, complex I is likely to be a physiologically more relevant site (Votyakova and Reynolds, 2001) . Therefore, interference with these mitochondrial complexes may increase ROS production. In this study, mitochondrial depolarization with the protonophore FCCP did not modify H2O2 generation induced by any of the tested compounds (Table 1) . Although a recent in vivo study suggests that MDMA may inhibit mitochondrial complex I (Puerta et al., 2010) , the absence of effects in our experimental conditions is probably due to the fact that the whole brain synaptosome model lacks in vivo factors, like hyperthermia, inflammation, cell signalling and excitotoxicity.
MDMA can increase lipid peroxidation in the mouse striatum (Camarero et al., 2002) and mitochondria from whole rat brain (Alves et al., 2007; . Though MAO-B strongly contributes to this effect in vivo (Alves et al., 2007; , in the present study, only the MDMA metabolite 5-(GSH)-a-MeDA significantly increased lipid peroxidation, in a concentration-and time-dependent manner ( Figure 4A ). It is noteworthy that during the preparation of synaptosomes, a significant proportion of brain mitochondria are lost, which may explain the absence of lipid peroxidation for 5-HT and dopamine, since MAO enzymes are located at the outer membrane of mitochondria. Lipid peroxidation induced by 5-(GSH)-a-MeDA was completely prevented by NAC ( Figure 4B) . Thus, the protective effect exerted by NAC on this process and in previous studies on MDMA metabolites (Capela et al., 2006; suggests that this antioxidant may be an interesting drug to prevent MDMA-induced neurotoxicity.
MDMA metabolite-related o-quinones may arylate macromolecules and thus lead to gross structural and functional modifications including protein fragmentation, protein carbonylation, generation of protein peroxides and enzyme inactivation (Carvalho et al., 2004a; 2004b; 2004c) . In accordance, we found a significant increase in protein carbonylation, not only with the MDMA metabolite 5-(GSH)-a-MeDA, but also with DOPAC. Also, an increase in quinoprotein levels was observed when synaptosomes were exposed to the MDMA metabolites a-MeDA, N-Me-a-MeDA and 5-(GSH)-a-MeDA, as previously observed in rat cortical neurons , as well as dopamine, L-DOPA and DOPAC, in a concentration-dependent but timeindependent manner ( Figure 5 ). The presence of the catechol group in these six compounds allows them to undergo redox cycling and the corresponding formation of o-quinones and subsequent binding to synaptosomal proteins. Likewise, the absence of the catechol group in the MDMA and 5-HT molecules explains the absence of increased quinoprotein levels for these compounds. Of note, the lower oxidation potential of these metabolites, when compared with the parent compound, correlated with a higher toxicity of these catechols to rat cortical neurons . Thus, the results herein shown for the H2O2 production, lipid peroxidation, quinoproteins Results are presented as mean Ϯ SD from 6 independent experiments, expressed in nmol GSH·mg -1 protein (A) or mM GSH in the supernatant (B). Statistical comparisons were made using one-way ANOVA followed by the Newman-Keuls multiple comparison post hoc test (*P < 0.05, **P < 0.01, ***P < 0.001 treatment vs. control; + P < 0.05, ++ P < 0.01, +++ P < 0.001 compound + BSO vs. BSO).
and protein carbonylation clearly demonstrate the high toxic potential of the MDMA metabolites, in particular 5-(GSH)-a-MeDA. GSH, the most abundant intracellular antioxidant, plays a major role in protecting biological systems against oxidative stress. Incubation of synaptosomes with the tested compounds, except MDMA and its metabolite a-MeDA, significantly increased GSSG levels and decreased intrasynaptosomal total GSH levels from the first to the second hour of exposure, which can be a direct consequence of the pro-oxidant activity promoted by these compounds. However, as we previously reported, for the MDMA metabolites, decreased GSH levels may, as well, be due to GSH conjugation with reactive o-quinones and/or aminochromes produced during oxidation of these compounds (Carvalho et al., 2004c; Capela et al., 2007) .
Administration of MDMA to rats causes oxidative stress in brain mitochondria (Alves et al., 2007; . With this in mind, and considering that MAO is located at the outer membrane of mitochondria, we evaluated possible consequences of 5-HT (MAO substrate) and the MDMA metabolites N-Me-a-MeDA and 5-(GSH)-a-MeDA on mitochondrial integrity. As observed, in this experimental model, the oxidative stress mediated by 5-HT, N-Me-a-MeDA and 5-(GSH)-a-MeDA did not induce detectable mitochondrial dysfunction, as monitored by the average number of polarized mitochondria.
In conclusion, our study in mouse brain synaptosomes demonstrated that there was an increase in ROS generation associated with damage to cellular macromolecules promoted by MDMA metabolites. Moreover, the increase in monoamine neurotransmitters promoted by MDMA, namely 5-HT and dopamine, or their metabolites, such as DOPAC, can equally promote oxidative stress and contribute to MDMA neurotoxicity.
Figure 9
Microphotographs of control synaptosomes using bright field microscopy (A) and TMRM fluorescence (B) at 60¥ magnification. (C) Effects of MDMA metabolites N-Me-a-MeDA and 5-(GSH)-a-MeDA as well as 5-HT on the number of polarized mitochondria. Synaptosomes were exposed to 200 mM of MDMA metabolites N-Me-a-MeDA and 5-(GSH)-a-MeDA as well as 5-HT, for 1 h, then incubated with 50 nM TMRM and imaged as described under Methods during 2 h. Results are presented as mean Ϯ SD from 6 independent experiments, expressed in percentage of control (number of polarized mitochondria per field, set to 100%). Statistical comparisons were made using one-way ANOVA followed by the NewmanKeuls multiple comparison post hoc test.
